Is a complete XGN research report available?

No complete published report is available for Exagen Inc. (XGN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Exagen Inc. (XGN)

NASDAQ: XGN · USD

$4.68

-0.27 (-5.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first XGN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	113.1M
Revenue (ttm)	68.4M
Net income (ttm)	-20.2M
EPS (ttm)	-$0.88
Shares out	24.2M
Volume	186,972
Beta	2.02
Price target	$8.57	+83.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 68.4M
Net income (ttm): -20.2M
EPS (ttm): -$0.88
Market cap: 113.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All XGN indicators

Market & fundamental data

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001274737
Company name	Exagen Inc.
Country	United States
Country code	US
Cusip	30068X103
Employees	220
Employees Change	5%
Employees Change Percent	2.33
Enterprise value	$118.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
Industry PE	42.46
Industry PE Fwd	25.83
IPO Date	2019-09-19
Isin	US30068X1037
Last refreshed	2026-07-25
Market cap	$113.1M
Market cap category	Micro-Cap
Price	$4.68
Price currency	USD
Rev Per Employee	310,831.82x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	8071
Symbol	XGN
Website	https://www.exagen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.8%
EV Sales Forward	1.64x
EV/Sales	1.74x
FCF yield	-12.47%
P/B ratio	8.26x
P/S ratio	1.66x
PS Forward	1.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-20.65%
EBITDA Margin	-17.32%
Gross margin	58.32%
Gross Profit	$39.9M
Gross Profit Growth	18.56%
Gross Profit Growth Q	11.86%
Gross Profit Growth3 Y	21.79%
Gross Profit Growth5 Y	8.72%
Net Income	$-20.2M
Net Income Growth Years	0%
Pretax Margin	-29.36%
Profit Margin	-29.49%
Profit Per Employee	$-91,664
ROA	-19.13
Roa5y	-18.54
ROCE	-35.84
ROE	-193.6
Roe5y	-86.22
ROIC	-24.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-36.09%
Cagr3y	23.08%
Cagr5y	-18.5%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	20.55x
Revenue Growth Q	11.67x
Revenue Growth Quarters	5x
Revenue Growth Years	3x
Revenue Growth3 Y	13.8x
Revenue Growth5 Y	9.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.48
Assets	$52M
Cash	$21.5M
Current Assets	$43.6M
Current Liabilities	$12.6M
Debt	$27.1M
Debt Equity	$1.88
Equity	$14.4M
Interest Coverage	-2.8
Liabilities	$37.5M
Long Term Assets	$8.4M
Long Term Liabilities	$25M
Net Cash	$-5.6M
Net Cash By Market Cap	$-4.97
Net Debt Equity	$0.39
Tangible Book Value	$14.4M
Tangible Book Value Per Share	$0.6
WACC	15.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.47
Inventory Turnover	6.44
Net Working Capital	$12.5M
Quick ratio	2.97
Working Capital	$31M
Working Capital Turnover	$2.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-24.66%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-36.07%
200-day SMA	5.43
3Y total return	86.45%
50-day SMA	4.46
50-day SMA vs 200-day SMA	50under200
5Y total return	-64.03%
All Time High	29.86
All Time High Change	-84.33%
All Time High Date	2019-12-26
All Time Low	1.3
All Time Low Change	260%
All Time Low Date	2024-04-16
ATR	0.35
Beta	2.02
Beta1y	1.86
Beta2y	1.07
Ch YTD	-23.03
High	5.11
High52	12.23
High52 Date	2025-10-27
High52ch	-61.73%
Low	4.65
Low52	2.59
Low52 Date	2026-03-30
Low52ch	80.7%
Ma50ch	5%
Price vs 200-day SMA	-13.75%
RSI	53.39
RSI Monthly	47.98
RSI Weekly	51.32
Sharpe ratio	-0.33x
Sortino ratio	-0.43
Total Return	-24.66%
Tr YTD	-23.03
Tr1m	7.46%
Tr1w	6.61%
Tr3m	74.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	3
Analyst Price Target Top	$8.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.19
Earnings Revenue Estimate	17,849,000x
Earnings Revenue Estimate Growth	3.76x
Operating Income	$-14.1M
Operating margin	-20.65
Price target	$8.57
Price Target Change	$83.12
Price Target Change Top	$85.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,807,356%
Float Percent	57.15%
Net Borrowing	2,721,000
Shares Insiders	18.54%
Shares Institutions	43.49%
Shares Out	24,159,839
Shares Qo Q	1.18%
Shares Yo Y	24.66%
Short Float	5.89%
Short Ratio	2.77
Short Shares	3.37

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-16.5M
Average Volume	234,421.3x
Bv Per Share	0.6
CAPEX	$-756,000
Ch1m	7.46
Ch1w	6.61
Ch1y	-36.07
Ch3m	74.63
Ch3y	86.45
Ch5y	-64.03
Ch6m	1.74
Change	-5.45%
Change From Open	-6.4
Close	4.95
Days Gap	1.01
Depreciation Amortization	2,277,000
Dollar Volume	875,029
Earnings Date	2026-08-04
Earnings Time	bmo
EBIT	$-14.1M
EBITDA	$-11.8M
EPS	$-0.88
F Score	3
FCF	$-14.1M
FCF EV Yield	-11.88x
FCF Per Share	$-0.58
Financing CF	24,437,000
Fiscal Year End	December
Founded	2,002
Income Tax	$87,000
Investing CF	-747,000
Ipr	-66.5
Iprfo	-72.08
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	4.06
Ma150ch	15.24%
Ma20	4.56
Ma20ch	2.7%
Net CF	10,319,000
Next Earnings Date	2026-08-04
Open	5
Optionable	Yes
Position In Range	6.52
Post Close	4.68
Postmarket Change Percent	-0.64
Postmarket Price	$4.65
Ppne	7,790,000
Price Date	2026-07-24
Ptbv Ratio	7.85
Relative Volume	0.8x
Revenue	68,383,000x
SBC By Revenue	3.5x
Share Based Comp	2,396,000
Tax By Revenue	0.13x
Tr6m	1.74%
Us State	California
Volume	186,972
Z Score	-4.98

Exagen Inc. (XGN)

Coverage state: Market snapshot only — no published research

Generate the first XGN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · XGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on XGN

Frequently asked questions